| |
|
|
|
CymaBay Therapeutics Inc.  
|
|
11.93 -0.99 (-0.08%) |
03-22 16:00 |
|
Open: |
12.83 |
Pre close: |
12.92 |
Target:
|
16.35
|
|
High: |
12.83 |
Low: |
11.92 |
Resistance:
|
14.00
16.35
|
|
Volume: |
1,234,855 |
Market Cap: |
819M |
Support:
|
11.11
9.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
12.89
 |
MACD |
MACD(12,26):
|
0.65 |
|
MA(20): |
12.64  |
Signal(12,26,9): |
0.83 |
|
MA(100): |
9.85 |
Stochastic Oscillator |
%K(14,3):
|
36.33 |
|
MA(250): |
11.27 |
%D(3): |
56.89 |
|
Average Volume(K) |
3-Month: |
70530
|
52-Week |
High:
|
15.00 |
|
10-Days: |
68170 |
Low: |
6.31 |
|
RSI |
RSI(14):
|
49.19 |
Change(%): |
-1.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.280 |
Return on Equity (ttm) |
-56.8 |
Shares Out. (M) |
59.47 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-49.9 |
Shares Float (M) |
59.06 |
|
EPS Est. Next Year |
-0.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.70 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
122.40 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
4.540 |
EBITDA (p.s.) |
0.000 |
P/E |
-9.32 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.63 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-54.94 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-34.14 |
P/CF |
-12.91 |
|
|
|
|
|
|
